PartnerFacts
Data last updated: Oct 23, 2026, 5:45 PM ETLatest filing: Oct 22, 2026Now: Oct 24, 2026, 10:43 AM ET

Sponsor Check › Person

DE
No photo found yet (own website and image search run after this page is viewed)

Daniel Estes

Named as an officer, director or promoter on SEC Form D filings · MA, CA, IN · Oct 22, 2019 → Feb 8, 2024

7deals (issuers)
$1.65Breported sold
202investors
12Form D filings
2019–2024years on file

Data last updated Oct 23, 2026, 5:45 PM ET · Courts (RECAP) last checked: Oct 24, 2026, 12:10 AM ET · SEC enforcement last checked: covered by the index scan as of Oct 24, 2026, 2:50 AM ET

The short version

Daniel Estes is listed as an executive officer, director, and promoter on 12 SEC Form D filings by 7 issuers between Mar 2016 and Mar 2025. Largest by amount reported sold: Frazier Life Sciences XI, L.P. (Menlo Park, CA — pooled investment fund — 2022; $960M reported sold to 98 investors), Frazier Life Sciences IX, L.P. (Seattle, WA — pooled investment fund — 2017; $418.9M reported sold to 55 investors), Arcutis Biotherapeutics, Inc. (Westlake Village, CA — biotechnology — 2019; $94.5M reported sold to 16 investors), Sudo Biosciences, Inc. (Carmel, IN — other technology — 2021–2024; $63.6M reported sold to 15 investors), Eyconis, Inc. (Redwood City, CA — industry reported as "Other" — 2024; $60.3M reported sold to 7 investors) and 2 more (all listed below).

What this means A repeat sponsor — 7 separate companies raised money with this person listed as executive officer, director, and promoter, over about 9 years. Across those companies the filings report $1.65B sold in total.

Listed alongside Scott Byrd (5 shared filings), Patrick Heron (4 shared filings), David A Socks (3 shared filings), James Topper (3 shared filings), Tadataka Yamada (3 shared filings) and 24 others.

What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Daniel. Each name links to their own page.

1 of the issuers belongs to the sponsor group Frazier Healthcare (26 issuers, $2.74B reported sold, 2012–2026).

What this means A sponsor group is one team that sets up a new company for each deal. Frazier Healthcare has 26 companies on file and $2.74B reported sold in total — the group page shows the whole track record in one place.

Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CO, CT, DC, DE, FINRA, FL, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, NY, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VT, WA, WI, WV, WY) — none found.

What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.

We compared 12 public filings for Daniel Estes and found 10 differences: Daniel Estes appears on 1 deal that stopped filing before reaching its target; 4 offerings have no amendment in the last 12 months and may still be open; and more below.

What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.

What the community is saying

Community search for Daniel Estes has not run yet — it is joining a line of 59,971 names; searches run around the clock at the hosts' allowed rate. Searched so far: 683 names.

Community comments are quoted as written by their authors. Sources searched: Bing (site:reddit.com / site:biggerpockets.com) and Reddit's own search, plus DuckDuckGo/Brave/BiggerPockets search when they are answering.

Key records

Five things investors ask first. Items still in human review are counted, not shown.

1. Lawsuits

None found in sources searched — federal courts (CourtListener / RECAP), checked Oct 24, 2026

What was searched

Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30) — federal district + bankruptcy courts State courts: not covered (one-tap state court links under Look further). PACER: not searched. · Last checked Oct 24, 2026, 12:10 AM ET.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

2. Regulatory actions

None found in sources searched — SEC enforcement releases (index scan as of Oct 24, 2026, 2:50 AM ET) · state securities regulators: 48 regulators (FINRA, NASAA, 37 states) — crawled Oct 24, 2026, 8:48 AM ET

What was searched

SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — Searched SEC litigation releases and administrative proceedings (1995→ / 2007→) (30,205 records as of Oct 24, 2026, 2:50 AM ET) — nothing matched Daniel Estes..

State securities regulators: Securities regulators searched (64,910 actions): FINRA (38,350 actions, 1995–2026), NASAA (31 actions, 2000–2026; listing starts 1997), AK Division of Banking and Securities (273 actions, 1971–2025), AL Securities Commission (880 actions, 2001–2026), AR Securities Department (1,305 actions, 1998–2026), AZ Corporation Commission Securities Division (411 actions, 2017–2026), CA DFPI (25 actions, 2007–2024; listing starts 2002 — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), CO Division of Securities (731 actions, 2001–2026; older years from the Internet Archive (snapshot of 2026-05-02)), CT Department of Banking Securities Division (940 actions, 2006–2026; older years from the Internet Archive (snapshot of 2026-04-22)), DC DISB Securities Bureau (25 actions, 2012–2026), DE DOJ Investor Protection Unit (257 actions, 1987–2026), FL Office of Financial Regulation (49 actions, 2018–2026), GA Secretary of State Securities Division (65 actions, 2015–2026; listing starts 2012), HI DCCA Securities Enforcement Branch (26 actions, 2012–2026), ID Department of Finance Securities Bureau (663 actions, 1994–2026), IL Secretary of State Securities Department (4,122 actions, 2003–2023), KS Insurance Department Securities Division (58 actions), KY Department of Financial Institutions (342 actions, 2005–2026), LA Office of Financial Institutions Securities Division (13 actions, 2010–2025; listing starts 2008), MA Secretary of the Commonwealth Securities Division (125 actions, 2012–2025; live site blocks automated access — loaded from the Internet Archive snapshot of 2026-02-04), MD Attorney General Securities Division (1,054 actions, 2004–2026), ME Office of Securities (539 actions, 2000–2026), MI LARA Corporations, Securities & Commercial Licensing Bureau (201 actions), MO Secretary of State Securities Division (919 actions, 1998–2026), MS Secretary of State Securities Division (209 actions, 1995–2026), MT Commissioner of Securities and Insurance (597 actions, 2000–2026), NC Secretary of State Securities Division (265 actions, 2004–2024), ND Securities Department (711 actions, 1990–2026; the regulator no longer publishes this list live — loaded from the Internet Archive snapshot of 2026-01-06), NH Bureau of Securities Regulation (402 actions, 2002–2026), NM Regulation and Licensing Department Securities Division (90 actions, 2010–2025), NV Secretary of State Securities Division (118 actions, 2018–2026), NY Attorney General Investor Protection Bureau (44 actions, 2012–2026), OH Division of Securities (327 actions, 1993–2006), OK Department of Securities (2,531 actions, 1998–2026), OR Division of Financial Regulation (589 actions, 1988–2026), PA Department of Banking and Securities (1,448 actions, 2008–2024; the regulator no longer publishes this list live — loaded from the Internet Archive snapshot of 2024-08-09), RI DBR Securities Division (98 actions, 2005–2025), SC Attorney General Securities Division (540 actions, 2006–2026), SD Division of Insurance – Securities Regulation (106 actions, 2017–2026), TN Department of Commerce and Insurance Securities Division (405 actions, 1992–2026), TX State Securities Board (936 actions, 1999–2026), UT Division of Securities (772 actions, 2000–2026; older years from the Internet Archive (snapshot of 2010-05-27)), VT DFR Securities Division (137 actions, 2010–2026), WA DFI (2,039 actions, 2001–2026), WI DFI Division of Securities (1,072 actions, 1998–2026), WV Securities Commission (State Auditor) (64 actions), WY Secretary of State Compliance Division (6 actions, 2016–2024) — last crawled Oct 24, 2026, 8:48 AM ET. No machine-readable public listing today for IA, IN, MN, NE, NJ, VA (see docs/state-regulators.md).

3. Bankruptcies

None found in sources searched — federal bankruptcy courts (CourtListener / RECAP), checked Oct 24, 2026

What was searched

Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not covered (one-tap state court links under Look further). PACER: not searched (RECAP only). · Last checked Oct 24, 2026, 12:10 AM ET.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

4. Differences between public sources

Comparisons cover issuers and sponsor groups — see the issuer pages under Deals

10 differences found between the filings for Daniel Estes (compared 12 filings on Oct 24, 2026)

Note · Feb 15, 2024

Daniel Estes appears on 1 deal that stopped filing before reaching its target

Sudo Biosciences, Inc. (last filing Feb 15, 2024; $63,596,587 sold of $161,763,255). Each has no filing in more than two years and reported under half its target sold.

What this means An issuer whose last filing is more than two years old and reported under half its target sold. The raise may have closed early or quietly stopped. Ask what happened to each.

Sources
Note · Mar 15, 2016 – Feb 15, 2024

4 offerings have no amendment in the last 12 months and may still be open

No amendment in the last 12 months on an offering that may still be open — Sudo Biosciences, Inc. (latest filing Feb 15, 2024) · No amendment in the last 12 months on an offering that may still be open — Eyconis, Inc. (latest filing Feb 8, 2024) · No amendment in the last 12 months on an offering that may still be open — Arcutis Biotherapeutics, Inc. (latest filing Oct 22, 2019) · No amendment in the last 12 months on an offering that may still be open — Outpost Medicine, LLC (latest filing Mar 29, 2016)

What this means SEC rules expect a yearly amendment while an offering is still going. Ask the sponsor which of these raises have closed.

Sources
Note · Dec 28, 2023 – Feb 15, 2024

Offering amount changed between filings — Sudo Biosciences, Inc.

The Dec 28, 2023 filing says $141,013,255 offered; the Feb 15, 2024 Form D/A says $161,763,255.

What this means The target raise changed. Raising the cap is common when a deal grows; ask whether the extra money has the same terms and use.

Sources
Note · May 5, 2021 – Mar 2, 2022

Offering amount changed between filings — Sudo Biosciences, Inc.

The May 5, 2021 filing says $10,000,000 offered; the Mar 2, 2022 Form D/A says $22,250,000.

What this means The target raise changed. Raising the cap is common when a deal grows; ask whether the extra money has the same terms and use.

Sources
Note · May 30, 2017 – Oct 12, 2018

Offering amount changed between filings — Outpost Medicine, LLC

The May 30, 2017 filing says $44,999,999 offered; the Oct 12, 2018 Form D/A says $55,999,999.

What this means The target raise changed. Raising the cap is common when a deal grows; ask whether the extra money has the same terms and use.

Sources
Note · Mar 29, 2016 – Nov 1, 2017

Daniel Estes is written 2 different ways on the filings

listed as "Daniel Estes" on 9 filings (from Mar 29, 2016), and "Daniel J. Estes" on 3 filings (from Nov 1, 2017).

What this means Same person, written differently — a middle name or suffix left off, or spelled another way. It is normal, but check that the full legal name matches your subscription documents.

Sources
Note · Apr 10, 2017

Same name, different state: "Daniel Estes" (MI) is a separate record

This page covers filings where the address state is MA or CA or IN. A separate record, "Daniel Estes" with address state MI, is listed on 1 filing — most recently by Cirius Therapeutics, Inc. (Apr 10, 2017). The two records do not overlap in time: this page runs Oct 22, 2019 to Feb 8, 2024; the other has one filing dated Apr 10, 2017.

What this means Could be the same person who moved, or two people with the same name. We keep them apart until a filing ties them together. Check both pages before you decide.

Sources
Note · Mar 2, 2022 – Dec 28, 2023

Address moved from Menlo Park, CA to Carmel, IN — Sudo Biosciences, Inc.

The people listed on the Mar 2, 2022 filing give Menlo Park, CA; on the Dec 28, 2023 filing they give Carmel, IN.

What this means Businesses move; this just shows the two places and dates. If you were told one city and the forms say another, ask which is current.

Sources
Note · May 30, 2017 – Oct 12, 2018

Address moved from Lexington, MA to Indianapolis, IN — Outpost Medicine, LLC

The people listed on the May 30, 2017 filing give Lexington, MA; on the Oct 12, 2018 filing they give Indianapolis, IN.

What this means Businesses move; this just shows the two places and dates. If you were told one city and the forms say another, ask which is current.

Sources
Note · Mar 29, 2016 – Mar 17, 2025

Daniel Estes is listed with 3 different address states: MA, CA, IN

MA on 2 filings (Mar 29, 2016 to May 30, 2017); CA on 7 filings (Nov 1, 2017 to Mar 17, 2025); IN on 3 filings (Oct 12, 2018 to Feb 15, 2024).

What this means The address on a Form D is usually the company's, not the person's home, so this often just reflects different companies. It can also mean a move. Nothing wrong by itself.

Sources
What is compared

What is compared: every Form D and D/A we hold for this subject, side by side — filing dates vs. first-sale dates (the 15-day rule), amendment timing on open offerings (the yearly-amendment expectation), amounts sold, investor counts, offering amounts and minimums across amendments, industry and size bands, addresses, how each person's name and role is written, paid sellers' CRD numbers, and (for groups) where the member companies were formed and sit. Everything is as filed by the issuer; the SEC does not check it. Differences are common and usually have ordinary explanations — we show both values, the dates, and the source so you can ask. As of Oct 24, 2026.

5. Money to insiders

None reported on 9 offerings — no sales commissions, finder's fees or proceeds to insiders

Per-offering detail
Offering (latest filing)Sales commissionsFinder's feesTo insidersPaid to sell itSource
Mar 17, 2025 D
Frazier Life Sciences XII, L.P.
File 021-541158
$0$0$0None listed on this filingEDGAR ↗
Feb 15, 2024 D/A
Sudo Biosciences, Inc.
File 021-501000
$0$0$0None listed on this filingEDGAR ↗
Feb 8, 2024 D
Eyconis, Inc.
File 021-504724
$0$0$0None listed on this filingEDGAR ↗
Mar 18, 2022 D
Frazier Life Sciences XI, L.P.
File 021-438073
$0$0$0None listed on this filingEDGAR ↗
Mar 2, 2022 D/A
Sudo Biosciences, Inc.
File 021-398288
$0$0$0None listed on this filingEDGAR ↗
Oct 22, 2019 D
Arcutis Biotherapeutics, Inc.
File 021-351627
$0$0$0None listed on this filingEDGAR ↗
Oct 12, 2018 D/A
Outpost Medicine, LLC
File 021-287636
$0$0$0None listed on this filingEDGAR ↗
Nov 1, 2017 D
Frazier Life Sciences IX, L.P.
File 021-297918
$0$0$0
The General Partner receives a fee for advisory services. The fee is generally a percentage of the aggregate subscriptions of the Issuer's limited partners (as set forth in the Issuer's partnership agreement).
None listed on this filingEDGAR ↗
Mar 29, 2016 D
Outpost Medicine, LLC
File 021-260210
$0$0$0None listed on this filingEDGAR ↗

Counts come from Form D Items 12–15 on the filings in our index (latest filing per offering; one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.

Counted across every filing this person is listed on (latest filing per offering, per issuer).

Deals 7

Every issuer that named Daniel Estes on a Form D, newest first. A Form D is the notice a company files after it starts selling a private investment.

Pooled Investment Fund

Frazier Life Sciences XII, L.P.

Palo Alto, CA · Mar 17, 2025
  • Mar 17, 2025 · D · $0 sold of Indefinite · 0 investors · min. No minimum reported · role: Executive Officer (Member of the General Partner of the General Partner) EDGAR ↗

No sales reported yet as of the latest filing. Daniel is listed as executive officer.

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Other Technology

Sudo Biosciences, Inc.

Carmel, IN · May 5, 2021 → Feb 15, 2024 · 4 filings
  • Feb 15, 2024 · D/A · $63,596,587 sold of $161,763,255 · 15 investors · min. No minimum reported · role: Director EDGAR ↗
  • Dec 28, 2023 · D · $53,346,588 sold of $141,013,255 · 12 investors · min. No minimum reported · role: Director EDGAR ↗
  • Mar 2, 2022 · D/A · $22,250,000 sold of $22,250,000 · 6 investors · min. No minimum reported · role: Director EDGAR ↗
  • May 5, 2021 · D · $9,523,810 sold of $10,000,000 · 1 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $63.6M from 15 investors (39% of the $161.8M target) as of the latest filing. Daniel is listed as director on 4 filings for this deal.

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Technology / 506(b) (17,390 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Other

Eyconis, Inc.

Redwood City, CA · Feb 8, 2024
  • Feb 8, 2024 · D · $60,251,247 sold of $150,001,250 · 7 investors · min. No minimum reported · role: Executive Officer, Director, Promoter EDGAR ↗

Raised $60.3M from 7 investors (40% of the $150M target) as of the latest filing. Daniel is listed as executive officer, director, promoter.

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other / 506(b) (18,678 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Pooled Investment Fund

Frazier Life Sciences XI, L.P.

Menlo Park, CA · Mar 18, 2022
  • Mar 18, 2022 · D · $960,000,000 sold of $960,000,000 · 98 investors · min. No minimum reported · role: Executive Officer (Member of the General Partner of the General Partner) EDGAR ↗

Raised $960M from 98 investors (100% of the $960M target) as of the latest filing. Daniel is listed as executive officer.

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Biotechnology

Arcutis Biotherapeutics, Inc.

Westlake Village, CA · Oct 22, 2019
  • Oct 22, 2019 · D · $94,499,967 sold of $94,500,000 · 16 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $94.5M from 16 investors (100% of the $94.5M target) as of the latest filing. Daniel is listed as director.

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Other

Outpost Medicine, LLC

Indianapolis, IN · Mar 29, 2016 → Oct 12, 2018 · 3 filings
  • Oct 12, 2018 · D/A · $55,999,999 sold of $55,999,999 · 11 investors · min. No minimum reported · role: Director EDGAR ↗
  • May 30, 2017 · D · $14,999,999 sold of $44,999,999 · 10 investors · min. No minimum reported · role: Director EDGAR ↗
  • Mar 29, 2016 · D · $15,543,778 sold of $41,543,778 · 10 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $56M from 11 investors (100% of the $56M target) as of the latest filing. Daniel is listed as director on 3 filings for this deal.

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other / 506(b) (18,678 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Pooled Investment Fund · group: Frazier Healthcare

Frazier Life Sciences IX, L.P.

Seattle, WA · Nov 1, 2017
  • Nov 1, 2017 · D · $418,925,000 sold of $418,925,000 · 55 investors · min. No minimum reported · role: Promoter EDGAR ↗

Raised $418.9M from 55 investors (100% of the $418.9M target) as of the latest filing. Daniel is listed as promoter.

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Other pages with the same name (1)

Separate person records under the same name, not combined with this page. Each line says whether it shares an issuer with this record.

  • Daniel Estes — MI, 1 issuer, Apr 10, 2017 → Apr 10, 2017 · no shared issuer

People around Daniel 29

Officers, directors, promoters and management entities named on the same filings, as of Oct 23, 2026, 5:45 PM ET.

Management entity

Frazier Management, L.L.C.

Promoter · 1 shared filing (1 issuer) · also on 4 other issuers

Frazier Management, L.L.C. is on 5 issuers in total — a repeat sponsor. Their page lists every one.

Management entity

FHMLS IX, L.L.C.

Executive Officer · 1 shared filing (1 issuer)

Listed on the same filings as Daniel Estes. Their page shows their other deals.

SB
No photo found yet (own website and image search run after this page is viewed)
Person

Scott Byrd

Executive Officer, Director · 5 shared filings (2 issuers)

Listed on the same filings as Daniel Estes. Their page shows their other deals.

PH
No photo found yet (own website and image search run after this page is viewed)
Person

Patrick Heron

Executive Officer, Director · 4 shared filings (4 issuers) · also on 30 other issuers

Patrick Heron is on 34 issuers in total — a repeat sponsor. Their page lists every one.

JT
No photo found yet (own website and image search run after this page is viewed)
Person

James Topper

Executive Officer · 3 shared filings (3 issuers) · also on 21 other issuers

James Topper is on 24 issuers in total — a repeat sponsor. Their page lists every one.

DS
No photo found yet (own website and image search run after this page is viewed)
Person

David A Socks

Executive Officer, Director, Promoter · 3 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Daniel Estes. Their page shows their other deals.

TY
No photo found yet (own website and image search run after this page is viewed)
Person

Tadataka Yamada

Director · 3 shared filings (1 issuer)

Listed on the same filings as Daniel Estes. Their page shows their other deals.

TG
No photo found yet (own website and image search run after this page is viewed)
Person

Terry Gould

Director · 3 shared filings (1 issuer) · also on 10 other issuers

Terry Gould is on 11 issuers in total — a repeat sponsor. Their page lists every one.

PB
No photo found yet (own website and image search run after this page is viewed)
Person

Peter Bisgaard

Director · 2 shared filings (1 issuer) · also on 14 other issuers

Peter Bisgaard is on 15 issuers in total — a repeat sponsor. Their page lists every one.

CY
No photo found yet (own website and image search run after this page is viewed)
Person

Chen Yu

Director · 2 shared filings (1 issuer) · also on 2 other issuers

Listed on the same filings as Daniel Estes. Their page shows their other deals.

BC
No photo found yet (own website and image search run after this page is viewed)
Person

Bhaskar Chaudhuri

Director · 2 shared filings (2 issuers) · also on 1 other issuer

Listed on the same filings as Daniel Estes. Their page shows their other deals.

JB
No photo found yet (own website and image search run after this page is viewed)
Person

Jim Bristol

Director · 2 shared filings (1 issuer)

Listed on the same filings as Daniel Estes. Their page shows their other deals.

CG
No photo found yet (own website and image search run after this page is viewed)
Person

Chris Gagliardi

Director · 2 shared filings (1 issuer)

Listed on the same filings as Daniel Estes. Their page shows their other deals.

EF
No photo found yet (own website and image search run after this page is viewed)
Person

Edd Fleming

Director · 2 shared filings (1 issuer)

Listed on the same filings as Daniel Estes. Their page shows their other deals.

SF
No photo found yet (own website and image search run after this page is viewed)
Person

Shinichiro Fuse

Director · 2 shared filings (1 issuer)

Listed on the same filings as Daniel Estes. Their page shows their other deals.

DJ
No photo found yet (own website and image search run after this page is viewed)
Person

David Johnson

Director · 2 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Daniel Estes. Their page shows their other deals.

CW
No photo found yet (own website and image search run after this page is viewed)
Person

Conrad Wang

Director · 1 shared filing (1 issuer) · also on 2 other issuers

Listed on the same filings as Daniel Estes. Their page shows their other deals.

YY
No photo found yet (own website and image search run after this page is viewed)
Person

Yvonne Yamanaka

Director · 1 shared filing (1 issuer) · also on 3 other issuers

Listed on the same filings as Daniel Estes. Their page shows their other deals.

EC
No photo found yet (own website and image search run after this page is viewed)
Person

Emmett Cunningham

Executive Officer, Director, Promoter · 1 shared filing (1 issuer) · also on 5 other issuers

Emmett Cunningham is on 6 issuers in total — a repeat sponsor. Their page lists every one.

AC
No photo found yet (own website and image search run after this page is viewed)
Person

Anna Chen

Executive Officer, Director, Promoter · 1 shared filing (1 issuer) · also on 2 other issuers

Listed on the same filings as Daniel Estes. Their page shows their other deals.

JM
No photo found yet (own website and image search run after this page is viewed)
Person

Jan Moller Mikkelsen

Director · 1 shared filing (1 issuer)

Listed on the same filings as Daniel Estes. Their page shows their other deals.

JS
No photo found yet (own website and image search run after this page is viewed)
Person

Jonathan T. Silverstein

Director · 1 shared filing (1 issuer) · also on 32 other issuers

Jonathan T. Silverstein is on 33 issuers in total — a repeat sponsor. Their page lists every one.

AA
No photo found yet (own website and image search run after this page is viewed)
Person

Alexander Asam

Director · 1 shared filing (1 issuer) · also on 2 other issuers

Listed on the same filings as Daniel Estes. Their page shows their other deals.

RS
No photo found yet (own website and image search run after this page is viewed)
Person

Ricky Sun

Director · 1 shared filing (1 issuer) · also on 2 other issuers

Listed on the same filings as Daniel Estes. Their page shows their other deals.

PM
No photo found yet (own website and image search run after this page is viewed)
Person

Peter Moldt

Director · 1 shared filing (1 issuer)

Listed on the same filings as Daniel Estes. Their page shows their other deals.

CY
No photo found yet (own website and image search run after this page is viewed)
Person

Chen Yu

Director · 1 shared filing (1 issuer)

Listed on the same filings as Daniel Estes. Their page shows their other deals.

TW
No photo found yet (own website and image search run after this page is viewed)
Person

Todd Franklin Watanabe

Executive Officer, Director · 1 shared filing (1 issuer)

Listed on the same filings as Daniel Estes. Their page shows their other deals.

GE
No photo found yet (own website and image search run after this page is viewed)
Person

Gordon Empey

Executive Officer, Promoter · 1 shared filing (1 issuer)

Listed on the same filings as Daniel Estes. Their page shows their other deals.

OS
No photo found yet (own website and image search run after this page is viewed)
Person

Oliver Boris Stauch

Executive Officer · 1 shared filing (1 issuer)

Listed on the same filings as Daniel Estes. Their page shows their other deals.

The team behind the deals

Sponsor group

Frazier Healthcare

26 issuers · 34 filings · $2.74B reported sold · 2012–2026

One team, 26 deal companies. Daniel Estes is listed on 1 of them.

Sources

Issuers are grouped when their Form D filings share related persons, a management entity or a business address (automatic match from the filings). "Listed" marks the issuers that name Daniel Estes.

Same business address

51 other issuers file from the same address (first 50 shown)

A shared address can mean the same team, a shared office building or a registered agent. It is a lead, not a conclusion.

Registrations and other filings

Business registration (state registry / Secretary of State)

Individuals are not matched to business registrations — registries list companies, and a name alone is not enough to tie a person to one. Officers and managers appear by name inside each matched company's record on the issuer pages. Registries searched: AL (Alabama Secretary of State — Business Entity Records (arc-sos.state.al.us), searched by issuer name, data as of Oct 24, 2026); CO (Colorado Secretary of State — Business Entities in Colorado (data.colorado.gov), data as of Oct 23, 2026); CT (Connecticut Secretary of the State — Business Registry (data.ct.gov), data as of Oct 24, 2026); FL (Florida Department of State, Division of Corporations — quarterly corporate data file (Sunbiz), data as of Oct 7, 2026); KY (Kentucky Secretary of State — Business Entity Search (sosbes.sos.ky.gov), searched by issuer name, data as of Oct 24, 2026); NY (New York Department of State — Corporations and Other Entities (data.ny.gov: All Filings + Active Corporations), data as of Oct 20, 2026); OR (Oregon Secretary of State — Active Businesses, All (data.oregon.gov), data as of Oct 20, 2026); PA (Pennsylvania Department of State — Registered Businesses, Current (data.pa.gov), data as of Oct 6, 2026); TX (Texas Comptroller — Active Franchise Taxpayers incl. Secretary of State file data (data.texas.gov), data as of Oct 24, 2026). Registries of other states have not been searched: many publish no bulk file and require a CAPTCHA or bot challenge on their search page, which we do not bypass (Delaware, for example, offers no public bulk file).

Adviser registration (Form ADV)

A person is never an adviser firm. 1 of the 7 issuers this person is listed on matches a Form ADV adviser (searched 24,962 advisers as of Oct 2, 2026): Frazier Life Sciences IX, L.P..

Other offering types (Regulation A and Regulation Crowdfunding)

Searched SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 (51,358 records as of Oct 23, 2026, 8:41 PM ET) — nothing matched this name.

Property records none — individuals are not matched

Property records are matched to companies only, never to individuals, so none are matched to Daniel Estes by design. Searched property records in Hillsborough County FL (Clerk recorded-document index Oct 14, 2026 to Oct 15, 2026 + FL DOR 2026 ownership roll), Miami-Dade County FL (FL DOR 2026 ownership roll), Harris County TX (HCAD 2026 ownership roll), Dallas County TX (DCAD 2026 ownership roll), New York City ACRIS documents and PLUTO ownership rows already retrieved for other issuers, Cook County IL sale and ownership rows already retrieved for other issuers (814,874 records as of Oct 23, 2026, 8:59 PM ET) for the 7 issuers this person is listed on — nothing matched.

Public profiles and social

Websites and social links of the issuers Daniel Estes is listed on: none on file. No website or social profile named in Frazier Life Sciences XI, L.P.'s SEC filings (Form C, Reg A, Form ADV; checked Oct 24, 2026). Web search for this name: #161,564 of 374,652 in line (1,386 issuers searched so far). One-tap searches: Look further ↓

Look further

One-tap searches on sites we do not index ourselves, with the name pre-filled (Menlo Park, CA). Each opens in a new tab; what you find there is not verified by PartnerFacts.

Change history

No corrections have been requested for this page.

Every fact links to its public-record source. Plain-English notes next to a fact are our reading of that fact, not a rating. Request a correction · Facts policy

Request a correction

Free. Logged with status: received → under review → fixed / confirmed with source.

Add a response

If this is you or your firm, add a sourced explanation next to any fact. Reviewed before publishing.

Monitor this person

Members get an email when Daniel Estes appears on a new Form D, or when a court case or SEC action is matched to them. See plans →